Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension
about
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trialAdministration time-dependent effects of combination therapy on ambulatory blood pressure in hypertensive subjects.Hypertension up to date: SPRINT to SPYRAL.Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
P2860
Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prevention And Treatment of Hy ...... or drug-resistant hypertension
@ast
Prevention And Treatment of Hy ...... or drug-resistant hypertension
@en
type
label
Prevention And Treatment of Hy ...... or drug-resistant hypertension
@ast
Prevention And Treatment of Hy ...... or drug-resistant hypertension
@en
prefLabel
Prevention And Treatment of Hy ...... or drug-resistant hypertension
@ast
Prevention And Treatment of Hy ...... or drug-resistant hypertension
@en
P2093
P2860
P1433
P1476
Prevention And Treatment of Hy ...... or drug-resistant hypertension
@en
P2093
Bryan Williams
David J Webb
Gordon McInnes
J Kennedy Cruickshank
Jackie Salsbury
Morris J Brown
Peter Sever
Steve Morant
P2860
P304
P356
10.1136/BMJOPEN-2015-008951
P577
2015-08-07T00:00:00Z